Answers are grounded in this paper and cite their sources.
Narrative review summarizes the efficacy of optical interventions for myopia control, indicating safe options and concerns.
Myopia is an escalating global public health issue. The earlier onset and increasing prevalence of high myopia heighten the lifetime risk of vision-threatening complications, making the control of childhood axial elongation a central objective of contemporary myopia management. This narrative review summarizes the mechanistic rationale, clinical efficacy, safety considerations, and practical implementation of three non-pharmacologic modalities: orthokeratology (Ortho-K), dual-focus/multifocal soft contact lenses (specifically MiSight 1 day), and repeated low-level red-light (RLRL) therapy. The review emphasizes evidence-based effect sizes and monitoring needs. Evidence from randomized trials, meta-analyses, guideline perspectives, and mechanism-oriented studies was synthesized, prioritizing axial length outcomes, with spherical equivalent refraction considered as a complementary endpoint where appropriate. Key randomized trials and meta-analyses indicate that Ortho-K reduces axial elongation compared to single-vision controls by approximately 0.19 mm at one year and 0.28 mm at two years. In contrast, MiSight 1 day demonstrates a sustained effect, showing roughly 0.32 mm less axial elongation over three years. While RLRL has exhibited large short-term effects in recent trials, the certainty of the evidence remains low, and long-term retinal safety and generalizability have yet to be fully established. Overall, Ortho-K and MiSight represent established optical options with consistent efficacy and defined safety profiles, whereas RLRL is a high-interest modality with promising signals but greater uncertainty regarding long-term retinal safety and durability. Clinicians should adopt a monitoring-forward approach centered on longitudinal axial length tracking, given the substantial inter-individual variability in progression rate and response.
No takes yet. Share an insight, caveat, or question.
Yunjin Lee (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: